Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Comparison of various antibiotics in treatment of uncomplicated pelvic inflammatory disease

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Fluoroquinolones; Levofloxacin; Metronidazole; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination; Ofloxacin

Criteria

Inclusion Criteria:

• Diagnosis of PID based on: pelvic discomfort- Direct lower abdominal tenderness;

• Adnexal tenderness on bimanual vaginal examination,

• Temperature > 38.0°C; - Elevated C-reactive protein value (CRP);

• Signed PIC/IC

Exclusion Criteria:

• Pregnancy

• Abnormal lab values